Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY® News Provided By Share This Article ®, bringing total doses to 600 million for 27 EU member states All doses expected to be delivered in 2021 BioNTech SE (Nasdaq: BNTX) today announced they will supply an additional 100 million doses of COMIRNATY ®, the companies’ COVID-19 vaccine, to the 27 European Union (EU) member states in 2021. This announcement is a result of the European Commission’s (EC) decision to exercise its option to purchase an additional 100 million doses under its expanded Advanced Purchase Agreement signed on 1. This brings the total number of doses to be delivered to the EU to 600 million.